Skip to main content
TipRanks
Go Ultimate75% OFF

Regenerative Medical Technology Group (RMTG) Stock Statistics & Valuation Metrics

6 Followers

Total Valuation

Regenerative Medical Technology Group has a market cap or net worth of $478.12K. The enterprise value is $21.03M.

Market Cap
$478.12K
Enterprise Value
$21.03M

Share Statistics

Regenerative Medical Technology Group has 13,738,968 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
13,738,968
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Regenerative Medical Technology Group’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 5.71%.

Return on Equity (ROE)
0.22
Return on Assets (ROA)
-1.74
Return on Invested Capital (ROIC)
5.71%
Return on Capital Employed (ROCE)
0.03
Revenue Per Employee
5.10M
Profits Per Employee
-7.81M
Employee Count
1
Asset Turnover
1.14
Inventory Turnover
14.37

Valuation Ratios

The current PE Ratio of Regenerative Medical Technology Group is -0.05. Regenerative Medical Technology Group’s PEG ratio is 0.00.

PE Ratio
-0.05
PS Ratio
0.05
PB Ratio
-0.01
Price to FCF
-0.80
Price to Operating Cash Flow
1.66
PEG Ratio
0.00

Income Statement

In the last 12 months, Regenerative Medical Technology Group had revenue of 5.10M and earned -7.81M in profits. Earnings per share was -0.62.

Revenue
5.10M
Gross Profit
2.81M
Operating Income
-867.16K
Pretax Income
-7.81M
Net Income
-7.81M
EBITDA
-83.56K
Earnings Per Share (EPS)
-0.62

Cash Flow

In the last 12 months, operating cash flow was 268.56K and capital expenditures -850,894, giving a free cash flow of -582.33K billion.

Operating Cash Flow
268.56K
Free Cash Flow
-582.33K
Free Cash Flow per Share
-0.04

Dividends & Yields

Regenerative Medical Technology Group pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-125.55%
Earnings Yield
-2134.23%

Stock Price Statistics

Beta
-1.58
52-Week Price Change
-42.37%
50-Day Moving Average
0.05
200-Day Moving Average
0.05
Relative Strength Index (RSI)
25.28
Average Volume (3m)
58.56K

Important Dates

Regenerative Medical Technology Group upcoming earnings date is ―, Before Open (Confirmed).

Last Earnings Date
Aug 20, 2026
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Regenerative Medical Technology Group as a current ratio of 0.03, with Debt / Equity ratio of -56.32%

Current Ratio
0.03
Quick Ratio
0.03
Debt to Market Cap
31.61
Net Debt to EBITDA
-222.73
Interest Coverage Ratio
-0.12

Taxes

In the past 12 months, Regenerative Medical Technology Group has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Regenerative Medical Technology Group EV to EBITDA ratio is 10.47, with an EV/FCF ratio of -35.86.

EV to Sales
2.22
EV to EBITDA
10.47
EV to Free Cash Flow
-35.86
EV to Operating Cash Flow
77.75

Balance Sheet

Regenerative Medical Technology Group has $1.32M in cash and marketable securities with $21.74M in debt, giving a net cash position of -$20.42M billion.

Cash & Marketable Securities
$1.32M
Total Debt
$21.74M
Net Cash
-$20.42M
Net Cash Per Share
-$1.49
Tangible Book Value Per Share
-$3.10

Margins

Gross margin is 58.55%, with operating margin of 0.46%, and net profit margin of -101.21%.

Gross Margin
58.55%
Operating Margin
0.46%
Pretax Margin
-101.21%
Net Profit Margin
-101.21%
EBITDA Margin
21.19%
EBIT Margin
17.34%

Analyst Forecast

The average price target for Regenerative Medical Technology Group is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
94.32%
EPS Growth Forecast
-158.38%

Scores

Smart Score
―
AI Score
43